Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months
In Liverpool, pharmacy valuation is 80-110 % of revenue (90 % average), with a regulated gross margin of 26-32 %. New creation is extremely rare (transfer/merger only).
Dominant profile: portuaire · touristique
Liverpool (England, United Kingdom) has about 498K inhabitants and shows port and logistics activity bringing daily inflow beyond residents, and strong tourist footfall boosting seasonal spending and average ticket. For a pharmacy project, this means a average average ticket and a setup cost close to the national average.
The market can still absorb a well-positioned entrant, provided a clear niche is targeted. Concretely, initial investment calibrated for Liverpool ranges from 800K GBP to 3.5M GBP, and Year 1 target revenue sits between 1.4M GBP and 4.3M GBP — a range that already factors in the local coefficients of this city (national average on costs, −5% vs average on purchasing power).
Competitive density: medium (clear niches still open).
Dominant players: regulated public-insurance sector, few private chains.
Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.
| Indicator | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Year 1 revenue | 1.4M GBP → 4.3M GBP | ×1,18 (ramp-up) | ×1,32 (steady-state) |
| Target net margin | negative to low | 4 % | 10 % |
| Working capital (days of revenue) | 45-60 d | 35-50 d | 30-45 d |
| Cumulative ROI | investment | ~50 % | Payback at 96 months |
These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Liverpool, United Kingdom (cost national average, income −5% vs average).
This page combines multiple data sources for a factual analysis calibrated on Liverpool.
MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.